The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Regulated Diversity of Heparan Sulfate
Open accessAbstract
heparan sulfate N-acetylated N-sulfated fibroblast growth factor platelet-derived growth factor N-deacetylase/N-sulfotransferase GlcN 6-O-sulfotransferase GlcN 3-O-sulfotransferase IdoA 2-O-sulfotransferase 3′-phosphoadenosine 5′-phosphosulfate. Large numbers of proteins in animal tissues occur immobilized in the extracellular space, at cell surfaces or in the extracellular matrix. Some are anchored through interactions with other proteins. However, current research increasingly implicates proteoglycans as scaffold structures, designed to accommodate proteins through noncovalent binding to their glycosaminoglycan side chains (1Kjellén L. Lindahl U. Annu. Rev. Biochem. 1991; 60: 443-475Crossref PubMed Scopus (1660) Google Scholar). In particular, heparan sulfate (HS)1 proteoglycans are recognized as ubiquitous protein ligands. Binding of proteins to HS chains may serve a variety of functional purposes, from simple immobilization or protection against proteolytic degradation to distinct modulation of biological activity. Because of such interactions HS proteoglycans are critically involved in a variety of biological phenomena at various levels of complexity, including organogenesis in embryonic development, angiogenesis, regulation of blood coagulation and growth factor/cytokine action, cell adhesion, lipid metabolism, etc. (2Lindahl U. Lidholt K. Spillmann D. Kjellén L. Thromb. Res. 1994; 75: 1-32Abstract Full Text PDF PubMed Scopus (341) Google Scholar, 3Salmivirta M. Lidholt K. Lindahl U. FASEB J. 1996; 10: 1270-1279Crossref PubMed Scopus (392) Google Scholar, 4Rosenberg R.D. Shworak N.W. Liu J. Schwartz J.J. Zhang L. J. Clin. Invest. 1997; 99: 2062-2070Crossref PubMed Scopus (253) Google Scholar). In this review we outline the evidence for regulated expression of specific domains in HS chains and its relation to selective protein binding. Further, we consider the current information on HS biosynthesis, with the aim of understanding the mechanisms in control of generating specific saccharide sequences. Contrary to heparin, which is synthesized exclusively as serglycin proteoglycan in connective tissue-type mast cells (1Kjellén L. Lindahl U. Annu. Rev. Biochem. 1991; 60: 443-475Crossref PubMed Scopus (1660) Google Scholar), the structurally related HS is produced by most mammalian (and many other) cell types. A variety of core proteins have been shown to carry HS chains, including agrin and perlecan in the extracellular matrix (5Iozzo R.V. Matrix Biol. 1994; 14: 203-208Crossref PubMed Scopus (126) Google Scholar) and the syndecan- and glypican-type species at the cell surface (6David G. FASEB J. 1993; 7: 1023-1030Crossref PubMed Scopus (373) Google Scholar). There is so far no evidence of any correlation between the structures of core proteins and those of the attached HS chains, whereas, conversely, the fine structure of the HS chains on a given proteoglycan species may differ between cell types (7Kato M. Wang H. Bernfield M. Gallagher J.T. Turnbull J.E. J. Biol. Chem. 1994; 269: 18881-18890Abstract Full Text PDF PubMed Google Scholar). The carbohydrate backbone in heparin and HS consists of alternating hexuronic acid (d-glucuronic acid (GlcA) or l-iduronic acid (IdoA)) and d-glucosamine (GlcN) units. The GlcN residues in heparin are predominantly N-sulfated, whereas those in HS show a more varied N-substitution pattern with appreciable proportions of both N-sulfated and N-acetylated and a smaller amount of N-unsubstituted GlcN units (3Salmivirta M. Lidholt K. Lindahl U. FASEB J. 1996; 10: 1270-1279Crossref PubMed Scopus (392) Google Scholar, 8Gallagher J.T. Walker A. Biochem. J. 1985; 230: 665-674Crossref PubMed Scopus (190) Google Scholar,9van den Born J. Gunnarsson K. Bakker M.A.H. Kjellén L. Kusche-Gullberg M. Maccarana M. Berden J.H.M. Lindahl U. J. Biol. Chem. 1995; 270: 31303-31309Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). These structures are generated through the formation of a [GlcA-GlcNAc]n polymer that is subsequently modified by partial N-deacetylation/N-sulfation of GlcNAc units, C-5 epimerization of GlcA to IdoA residues, and, finally, incorporation of O-sulfate groups at various positions (Fig. 1). Compositional analysis of several HS preparations derived from different bovine organs revealed certain domain characteristics of unexpected regularity (10Maccarana M. Sakura Y. Tawada A. Yoshida K. Lindahl U. J. Biol. Chem. 1996; 271: 17804-17810Abstract Full Text Full Text PDF PubMed Scopus (240) Google Scholar). Thus 20–30% of the disaccharide units in all preparations were consistently arranged in alternatingN-acetylated and N-sulfated sequence (NA/NS domain in Fig. 1). Moreover, although the proportions of consecutiveN-sulfated disaccharide units (NS domain in Fig. 1) varied between preparations, those of IdoA residues within the NS domains and the extent of 2-O-sulfation of these units were remarkably constant. Very few 2-O-sulfate groups were located outside
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
PROTEOGLYCANS: STRUCTURES AND INTERACTIONS
Kjellén, L., & Lindahl, U. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.002303 · Cited by 1,719
Self-citationProteoglycans: Structures And Interactions
Kjellen, L. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.60.1.443 · Cited by 1,594
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Heparin : chemical and biological properties, clinical applications
Lane, D. A., & Lindahl, U. (1989) · Edward Arnold eBooks · Cited by 533
Self-citationGuimond, S., Maccarana, M., Olwin, B. B., Lindahl, U., & Rapraeger, A. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80471-2 · Cited by 481
Self-citationMinimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana, M., Casu, B., & Lindahl, U. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80470-0 · Cited by 454
Self-citationHeparan sulfate: a piece of information
Salmivirta, M., Lidholt, K., & Lindahl, U. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836040 · Cited by 439
Self-citationIntegral membrane heparan sulfate proteoglycans
David, G. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370471 · Cited by 418
Koenig, A., Norgard-Sumnicht, K., Linhardt, R., & Varki, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1509 · Cited by 403
Cited by
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,054
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Molecular diversity of heparan sulfate
Esko, J. D., & Lindahl, U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13530 · Cited by 951
Self-citationThe splice variants of vascular endothelial growth factor (VEGF) and their receptors
Robinson, C. J., & Stringer, S. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.853 · Cited by 944
Heparin and heparan sulfate: Structure and function
Rabenstein, D. L. (2002) · Natural Product Reports · doi:10.1039/b100916h · Cited by 870
Specificities of heparan sulphate proteoglycans in developmental processes
Perrimon, N., & Bernfield, M. (2000) · Nature · doi:10.1038/35008000 · Cited by 714
Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Bandtlow, C. E., & Zimmermann, D. R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1267 · Cited by 632
Herpes simplex virus: receptors and ligands for cell entry
Spear, P. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00389.x · Cited by 581
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 567
Glycosaminoglycans: key players in cancer cell biology and treatment
Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão, M. S., Tzanakakis, G. N., & Karamanos, N. K. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08529.x · Cited by 554
Sulfotransferases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic Utility
Chapman, E., Best, M. D., Hanson, S. R., & Wong, C. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300631 · Cited by 543
Three Classes of Cell Surface Receptors for Alphaherpesvirus Entry
Spear, P. G., Eisenberg, R. J., & Cohen, G. H. (2000) · Virology · doi:10.1006/viro.2000.0529 · Cited by 516
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K., Sweeney, M., & Proudfoot, A. E. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161747 · Cited by 508
2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and Activity
Linhardt, R. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030176m · Cited by 493
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-Gullberg, M., Eriksson, I., Ledin, J., Hellman, L., & Kjellén, L. (1999) · Nature · doi:10.1038/23488 · Cited by 481
Self-citationHeparan sulfate: decoding a dynamic multifunctional cell regulator
Turnbull, J., Powell, A., & Guimond, S. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01897-3 · Cited by 474
Ai, X., Do, A.-T., Lozynska, O., Kusche-Gullberg, M., Lindahl, U., & Emerson, C. P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212083 · Cited by 444
Self-citationSyndecans: proteoglycan regulators of cell-surface microdomains?
Couchman, J. R. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1257 · Cited by 430
Lind, T., Tufaro, F., McCormick, C., Lindahl, U., & Lidholt, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26265 · Cited by 429
Self-citationHeparan Sulfate: A Complex Polymer Charged with Biological Activity
Whitelock, J. M., & Iozzo, R. V. (2005) · Chemical Reviews · doi:10.1021/cr010213m · Cited by 410
Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Xu, Y., Masuko, S., Takieddin, M., Xu, H., Liu, R., Jing, J., Mousa, S. A., Linhardt, R. J., & Liu, J. (2011) · Science · doi:10.1126/science.1207478 · Cited by 407
Ghosh, T., Chattopadhyay, K., Marschall, M., Karmakar, P., Mandal, P., & Ray, B. (2009) · Glycobiology · doi:10.1093/glycob/cwn092 · Cited by 391
Control of Multivalent Interactions by Binding Epitope Density
Cairo, C. W., Gestwicki, J. E., Kanai, M., & Kiessling, L. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016727k · Cited by 383
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions
Tumova, S., Woods, A., & Couchman, J. R. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00116-8 · Cited by 375
Structure and biological interactions of heparin and heparan sulfate
Casu, B., & Lindahl, U. (2001) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(01)57017-1 · Cited by 375
Self-citationBaeg, G.-H., Lin, X., Khare, N., Baumgartner, S., & Perrimon, N. (2001) · Development · doi:10.1242/dev.128.1.87 · Cited by 371
Cell Surface Heparan Sulfate Proteoglycans: Selective Regulators of Ligand-Receptor Encounters
Park, P. W., Reizes, O., & Bernfield, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000008200 · Cited by 360
Götte, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0739rev · Cited by 348
The Molecular Diversity of Glycosaminoglycans Shapes Animal Development
Bülow, H. E., & Hobert, O. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093433 · Cited by 344
Heparin and heparan sulfate: biosynthesis, structure and function
Sasisekharan, R. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00145-9 · Cited by 326
Amara, A., Lorthioir, O., Valenzuela, A., Magerus, A., Thelen, M., Montes, M., Virelizier, J.-L., Delepierre, M., Baleux, F., Lortat-Jacob, H., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23916 · Cited by 323
Conformation and dynamics of heparin and heparan sulfate
Mulloy, B., & Forster, M. J. (2000) · Glycobiology · doi:10.1093/glycob/10.11.1147 · Cited by 315
Cell surface heparan sulfate and its roles in assisting viral infections
Liu, J., & Thorp, S. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1026 · Cited by 311
Heparan Sulfate: Biosynthesis, Structure, and Function
(2016) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2016.02.009 · Cited by 298
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry
Akhtar, J., & Shukla, D. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07402.x · Cited by 292
“3) [7,27].”
BackgroundInfluentialDechecchi, M. C., Melotti, P., Bonizzato, A., Santacatterina, M., Chilosi, M., & Cabrini, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8772-8780.2001 · Cited by 291
Toyoda, H., Kinoshita-Toyoda, A., & Selleck, S. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2269 · Cited by 287
GLYCOMICS APPROACH TO STRUCTURE-FUNCTION RELATIONSHIPS OF GLYCOSAMINOGLYCANS
Sasisekharan, R., Raman, R., & Prabhakar, V. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095745 · Cited by 278
Derksen, P. W. B., Keehnen, R. M. J., Evers, L. M., van Oers, M. H. J., Spaargaren, M., & Pals, S. T. (2002) · Blood · doi:10.1182/blood.v99.4.1405 · Cited by 274
Chapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(09)76003-4 · Cited by 274
Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts
Bryers, J. D., Giachelli, C. M., & Ratner, B. D. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24559 · Cited by 271
Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions
Iozzo, R. V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13560 · Cited by 264
Heparan sulfate proteoglycans in invasion and metastasis
Sanderson, R. D. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0241 · Cited by 262
The Elusive Functions of Proteoglycans
Lander, A. D., & Selleck, S. B. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.227 · Cited by 260
Sequencing Complex Polysaccharides
Venkataraman, G., Shriver, Z., Raman, R., & Sasisekharan, R. (1999) · Science · doi:10.1126/science.286.5439.537 · Cited by 257
Powell, A. K. (2004) · Glycobiology · doi:10.1093/glycob/cwh051 · Cited by 257
Ringvall, M., Ledin, J., Holmborn, K., van Kuppevelt, T., Ellin, F., Eriksson, I., Olofsson, A.-M., Kjellén, L., & Forsberg, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000359200 · Cited by 217
Self-citationTornberg, J., Sykiotis, G. P., Keefe, K., Plummer, L., Hoang, X., Hall, J. E., Quinton, R., Seminara, S. B., Hughes, V., Van Vliet, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102284108 · Cited by 177
Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function
Grobe, K., Inatani, M., Pallerla, S. R., Castagnola, J., Yamaguchi, Y., & Esko, J. D. (2005) · Development · doi:10.1242/dev.01935 · Cited by 173
Heparan sulfate: lessons from knockout mice
Forsberg, E., & Kjellén, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113561 · Cited by 214
Self-citationGonçalves, E., Kitas, E., & Seelig, J. (2006) · Biochemistry · doi:10.1021/bi052221t · Cited by 28
Shuvaev, V. V., Laffont, I., & Siest, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01285-5 · Cited by 27
Metadata
- Authors
- Lindahl, U., Kusche-Gullberg, M., & Kjellén, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-09
- Volume
- 273
- Issue
- 39
- Pages
- 24979-24982
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1971540677
- Cited by
- 678
- References
- 56
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.